Pretransplant Elevated Plasma Fibrinogen Level is a Novel Prognostic Predictor for Hepatocellular Carcinoma Recurrence and Patient Survival Following Liver Transplantation.

MLA

Wang, Guo-Ying, et al. “Pretransplant Elevated Plasma Fibrinogen Level Is a Novel Prognostic Predictor for Hepatocellular Carcinoma Recurrence and Patient Survival Following Liver Transplantation.” Annals of Transplantation, vol. 21, Feb. 2016, pp. 125–30. EBSCOhost, https://doi.org/10.12659/aot.895416.

APA

Wang, G.-Y., Jiang, N., Yi, H.-M., Wang, G.-S., Zhang, J.-W., Li, H., Zhang, J., Zhang, Q., Yang, Y., & Chen, G.-H. (2016). Pretransplant Elevated Plasma Fibrinogen Level is a Novel Prognostic Predictor for Hepatocellular Carcinoma Recurrence and Patient Survival Following Liver Transplantation. Annals of Transplantation, 21, 125–130. https://doi.org/10.12659/aot.895416

Chicago

Wang, Guo-Ying, Nan Jiang, Hui-Min Yi, Gen-Shu Wang, Jian-Wen Zhang, Hua Li, Jian Zhang, Qi Zhang, Yang Yang, and Gui-Hua Chen. 2016. “Pretransplant Elevated Plasma Fibrinogen Level Is a Novel Prognostic Predictor for Hepatocellular Carcinoma Recurrence and Patient Survival Following Liver Transplantation.” Annals of Transplantation 21 (February): 125–30. doi:10.12659/aot.895416.